NovoCure Limited (NVCR) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novocure Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.036 Good day, and thank you for standing by. Welcome to the NovoCure third quarter 2025 earnings 00:00:04.036 -- 00:00:07.561 call. At this time, all participants are on a listen-only mode. 00:00:07.561 -- 00:00:10.525 After the speaker's presentation, there'll be a question and answer session. 00:00:10.525 -- 00:00:13.909 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:13.909 -- 00:00:16.753 You will then hear an automated message advising your hand is raised. 00:00:16.753 -- 00:00:19.596 To withdraw your question, please press star 1-1 again. 00:00:19.596 -- 00:00:22.200 Please be advised, today's conference is being recorded. 00:00:22.200 -- 00:00:24.102 I would now like to hand the conference over to your speaker today. 00:00:24.102 -- 00:00:27.684 Ingrid Goldberg, please go ahead. 00:00:28.328 -- 00:00:34.412 Good morning. And thank you for joining us to review Novocare's third quarter 2025 performance. 00:00:34.412 -- 00:00:39.479 I'm on the phone this morning with our executive chairman, Bill Doyle, CEO, Ashley Cordova, 00:00:39.479 -- 00:00:44.045 and CFO, Christoph Brockman. Other members of our executive leadership team will be available 00:00:44.045 -- 00:00:45.627 for Q&A. 00:00:45.627 -- 00:00:50.394 For your reference, slides accompanying this earnings release can be found on our website, 00:00:50.394 -- 00:00:52.394 www.novacare.com, 00:00:52.516 -- 00:00:56.222 on the investor relations page under quarterly reports. 00:00:56.222 -- 00:00:59.762 Before we start, I would like to remind you, that our discussions during this conference 00:00:59.762 -- 00:01:03.726 call will include forward-looking statements, and actual results could differ materially 00:01:03.726 -- 00:01:07.469...